Table 2.

Clinical outcomes for adverse effects

All data	≤G1	G2	G3	G4	G5
Pharmacological pneumonitis	43 (97.7%)	0	0	0	1 (2.3%)
Lung infection	43 (97.7%)	0	0	0	1 (2.3%)
Radiation pneumonitis	40 (90.9%)	3 (9.1%)	1 (2.3%)	0	0
Pulmonary effusion	42 (95.5%)	1 (2.3%)	1 (2.3%)	0	0
Pericardial effusion	33 (75.0%)	11 (25.0%)	0	0	0
X-ray group	≤G1	G2	G3	G4	G5
Pharmacological pneumonitis	18 (94.7%)	0	0	0	1 (5.3%)
Lung infection	18 (94.7%)	0	0	0	1 (5.3%)
Radiation pneumonitis	15 (78.9%)	3 (15.8%)	1 (5.3%)	0	0
Pulmonary effusion	17 (89.5%)	1 (5.3%)	1 (5.3%)	0	0
Pericardial effusion	9 (47.4%)	10 (52.6%)	0	0	0
Proton group	≤G1	G2	G3	G4	G5
Pharmacological pneumonitis	25 (100%)	0	0	0	0
Lung infection	25 (100%)	0	0	0	0
Radiation pneumonitis	25 (100%)	0	0	0	0
Pulmonary effusion	25 (100%)	0	0	0	0
Pericardial effusion	24 (96.0%)	1 (4.0%)	0	0	0